Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase

Abstract

Myeloperoxidase (MPO) binds H2O2 in the absence and presence of chloride (Cl−) and catalyzes the formation of potent oxidants through 1e− and 2e− oxidation pathways. These potent oxidants have been implicated in the pathogenesis of various diseases including atherosclerosis, asthma, arthritis, and cancer. Thus, inhibition of MPO and its by-products may have a wide application in biological systems. Using direct rapid kinetic measurements and H2O2-selective electrodes, we show that tryptophan (Trp), an essential amino acid, is linked kinetically to the inhibition of MPO catalysis under physiological conditions. Trp inactivated MPO in the absence and presence of plasma levels of Cl−, to various degrees, through binding to MPO, forming the inactive complexes Trp–MPO and Trp–MPO–Cl, and accelerating formation of MPO Compound II, an inactive form of MPO. Inactivation of MPO was mirrored by the direct conversion of MPO–Fe(III) to MPO Compound II without any sign of Compound I accumulation. This behavior indicates that Trp binding modulates the formation of MPO intermediates and their decay rates. Importantly, Trp is a poor substrate for MPO Compound II and has no role in destabilizing complex formation. Thus, the overall MPO catalytic activity will be limited by: (1) the dissociation of Trp from Trp–MPO and Trp–MPO–Cl complexes, (2) the affinity of MPO Compound I toward Cl− versus Trp, and (3) the slow conversion of MPO Compound II to MPO–Fe(III). Importantly, Trp-dependent inhibition of MPO occurred at a wide range of concentrations that span various physiological and supplemental ranges.